Inovio Pharmaceuticals, Inc.

NASDAQ: INO
$14.34
-$0.52 (-3.5%)
Closing price June 2, 2020
The Wuhan Coronavirus has escaped China, with the number of cases and the death toll rising. The economic impact beyond the loss of life and suffering is real in many stocks, sectors and local...
Jon C. Ogg
The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As the death toll and number of infected are rising each hour, the economic...
Jon C. Ogg
New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical products company Cerus.
Chris Lange
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
Chris Lange
Inovio Pharma shares dipped on Wednesday after the company said that it was taking measures to cut costs and its overall burn rate. When a company says it’s cutting costs one thing it can mean is...
Chris Lange
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Chris Lange
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex Pharmaceuticals and Voya Financial.
Jon C. Ogg
We screened our 24/7 Wall St. research database and found five stocks trading under the $5 level that could prove exciting additions to portfolios looking for solid alpha potential.
Lee Jackson
We screened our 24/7 Wall St. research database and found five biotech stocks trading under the $10 level that could provide investors with some solid upside potential.
Lee Jackson
Inovio Pharmaceuticals shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial of its treatment for cervical dysplasia caused by human...
Chris Lange
Shares of Inovio Pharmaceuticals saw a handy gain early on Wednesday after the company gave an update on its Zika virus study.
Chris Lange
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Jon C. Ogg
Shares of Inovio Pharmaceuticals saw a massive gain early on Wednesday after the company announced a critical update from its HIV vaccine.
Chris Lange
Inovio Pharmaceuticals shares saw a handy gain on Wednesday after the company reported positive results from its early-stage Zika trial.
Chris Lange